KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 131 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $174,000 | -15.1% | 42,660 | -3.4% | 0.02% | -27.3% |
| Q4 2017 | $205,000 | -49.9% | 44,160 | -23.4% | 0.03% | -44.1% |
| Q3 2017 | $409,000 | -15.7% | 57,660 | -14.0% | 0.06% | -20.3% |
| Q2 2017 | $485,000 | +10.7% | 67,060 | -5.7% | 0.07% | +10.4% |
| Q1 2017 | $438,000 | +4.0% | 71,110 | -1.1% | 0.07% | -2.9% |
| Q4 2016 | $421,000 | +3.7% | 71,910 | -6.0% | 0.07% | +11.3% |
| Q3 2016 | $406,000 | -23.1% | 76,510 | -4.0% | 0.06% | -26.2% |
| Q2 2016 | $528,000 | +38.9% | 79,710 | -2.1% | 0.08% | +162.5% |
| Q1 2016 | $380,000 | -10.8% | 81,410 | -3.6% | 0.03% | -52.9% |
| Q4 2015 | $426,000 | +24.2% | 84,410 | -13.3% | 0.07% | +25.9% |
| Q3 2015 | $343,000 | -55.3% | 97,410 | +26.7% | 0.05% | -54.2% |
| Q2 2015 | $767,000 | – | 76,885 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
| HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
| Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
| Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
| SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
| Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
| DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
| NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |